News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Tak Paul Peter
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/02/2023 |
4
| Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns:
| Granted 180,000 options to buy
@ $1.29, valued at
$232.2k
|
|
12/12/2022 |
4
| Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns:
| Bought 3,050 shares
@ $1.7, valued at
$5.2k
Bought 12,935 shares
@ $1.92, valued at
$24.8k
|
|
11/30/2022 |
4
| Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns:
| Granted 195,906 shares
@ $0 |
|
03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|